Several other research analysts also recently commented on ISRG. Stifel Nicolaus reduced their price objective on Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating on the stock in a report on Friday, January 25th. Cantor Fitzgerald reiterated a “buy” rating and issued a $620.00 price target on shares of Intuitive Surgical in a report on Friday, January 25th. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, January 30th. Royal Bank of Canada set a $560.00 price target on Intuitive Surgical and gave the company a “hold” rating in a report on Thursday, February 28th. Finally, Raymond James lifted their price target on Intuitive Surgical from $600.00 to $630.00 and gave the company an “outperform” rating in a report on Monday, April 1st. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $576.82.
ISRG opened at $473.78 on Friday. The firm has a market cap of $54.93 billion, a price-to-earnings ratio of 49.92, a PEG ratio of 4.22 and a beta of 1.02. Intuitive Surgical has a 52 week low of $430.24 and a 52 week high of $589.32.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). The firm had revenue of $974.00 million for the quarter, compared to analysts’ expectations of $975.27 million. Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. The company’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.44 earnings per share. As a group, equities analysts predict that Intuitive Surgical will post 9.4 earnings per share for the current fiscal year.
In other news, Director Lonnie M. Smith sold 210 shares of the firm’s stock in a transaction on Tuesday, February 26th. The stock was sold at an average price of $546.56, for a total value of $114,777.60. Following the completion of the sale, the director now owns 359,246 shares of the company’s stock, valued at approximately $196,349,493.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Salvatore Brogna sold 2,090 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $551.79, for a total value of $1,153,241.10. The disclosure for this sale can be found here. Insiders sold a total of 28,619 shares of company stock worth $14,444,692 over the last quarter. Company insiders own 1.70% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Icon Wealth Partners LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth $26,000. Stone House Investment Management LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth $31,000. Advisory Alpha LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth $32,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $32,000. Finally, Athena Capital Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $33,000. 85.35% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
See Also: Oversold
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.